<DOC>
	<DOCNO>NCT00576498</DOCNO>
	<brief_summary>Primary Aim : In patient endoscopically suspect BE , compare standard endoscopy , novel technique ( NBI AFI ) target biopsy - Detect patient intestinal metaplasia - Detect area high grade dysplasia - Require few biopsy short time procedure completion Secondary Aim : - Compare yield high-grade dysplasia ( HGD ) use NBI/AFI versus standard endoscopy biopsy . - Compare number biopsy procedure time NBI/AFI versus standard endoscopy biopsy . - Compare inter-observer variability classify different mucosal vascular pattern observe NBI/AFI use kappa statistic .</brief_summary>
	<brief_title>Novel Imaging Techniques Barrett 's Esophagus</brief_title>
	<detailed_description>Barrett 's esophagus ( BE ) pre-malignant lesion adenocarcinoma esophagus esophagogastric junction . It condition squamous mucosa distal esophagus replace columnar mucosa , specifically intestinal metaplasia . The incidence esophageal adenocarcinoma rapidly rise increase 3-6 fold past two decade . This driven effort identify patient pre-malignant lesion i.e . BE . Intestinal metaplasia within columnar line esophagus epithelial type predispose patient development adenocarcinoma ; two epithelial type cardiac fundic . Since intestinal metaplasia include definition epithelial type associate cancer , obtain biopsy columnar line distal esophagus mandatory . The sensitivity positive predictive value standard EGD diagnosing BE report 82 % 34 % respectively . This secondary patchy mosaic presence intestinal metaplasia columnar distal esophagus . Endoscopic screen advocated patient chronic GERD symptom detection BE random biopsy obtain columnar appear distal esophagus visualize . Once intestinal metaplasia detect random biopsy diagnosis BE confirm , patient subsequently enrol surveillance program . Similarly , presence dysplasia early adenocarcinoma within segment BE patchy focal standard endoscopy random biopsy may fail detect lesion . New endoscopic imaging technique improve accuracy endoscopic diagnosis recently develop , currently evaluation . METHODS Study Overview : Patient present GI lab BE screen surveillance Informed consent sign patient randomize , endoscopic BE suspect NBI target biopsy standard endoscopy biopsy first procedure If randomize NBI first : pattern note , target biopsy obtain specific pattern Same patient return 3-6 week 2nd procedure Standard endoscopy : 4 quadrant every 2 cm . random biopsy ( i.e . standard BE surveillance ) Findings NBI random biopsy compare patient complete protocol result analyze A process similar one outline use compare autofluorescence image conventional endoscopy patient Barrett 's mucosa . Study Design : This study part multicenter randomize control trial conduct two site , one Medical University South Carolina . Patients randomize ( opaque seal envelope generate statistician ) undergo NBI/AFI standard endoscopy biopsy day 1 . The patient return alternative procedure biopsy within 3-6 week 1st procedure maintain acid suppressive therapy time interval . Each patient thus act his/her control . At time perform 2nd procedure ( either NBI/AFI target biopsy standard endoscopy ) , endoscopist blind aware biopsy result 1st procedure . Every attempt also make keep endoscopists blind past history patient i.e . non dysplastic BE , LGD , HGD etc . Risk benefit study participant : Data newer image method like NBI AFI mostly form case series . This lead change standard care . The early data encouraging conclusive due lack randomize , control trial . Hence , choose study design randomize controlled trial newer modality versus exist conventional endoscopy . This design necessitate performance repeat endoscopy . Upper endoscopy safe , routinely do procedure low risk complication . A repeat procedure may , indeed , increase potential risk associate procedure magnitude small . The added advantage second endoscopy would increase detection dysplasia adenocarcinoma result potential benefit patient . The main reason performance current study limitation conventional endoscopy implication dysplasia adenocarcinoma miss initial endoscopy . In clinical practice , usually warrant follow endoscopy perform 1-3 yr interval due time cost constraint . For study population trial , second endoscopy potential increase detection dysplasia/early adenocarcinoma Barrett 's segment could lead initiation curative therapy . Study Population : Patients undergo BE screen surveillance enrol write , informed consent . BE definition- columnar mucosa distal esophagus length intestinal metaplasia biopsy . The BE length measure gastroesophageal junction proximally displace squamo-columnar junction . The patient demographic ( age , gender ethnicity ) BE length record . Total time require procedure record - endoscope insertion removal . Narrow Band Imaging : Patients evaluate standard magnification endoscope ( Olympus GIF Q240Z , 115x GIF-H180 equivalent ) use NBI light source ( already available center ) . The outer diameter endoscope 10.8 mm similar standard diagnostic endoscope . No special processing clean endoscope require - similar standard Olympus GIF-100 . A cap may may fit distal tip endoscope allow mucosa contact cap magnify without motility esophagus affect visualization . The different pattern group ridge/villous , circular irregular/distorted . Target biopsies standard biopsy forceps obtain different visualized pattern separate jar . Autofluorescence Imaging : Patients evaluate use prototype autofluorescence endoscope ( Olympus , Tokyo , Japan ; excitation 395-475 nm , fluorescence detection 490-625 nm , red reflectance 600-620 nm green reflectance 540-560 nm ) . The AFI scope two different CCD ( charge couple device detect light wave emitted/reflected biological tissue - similar chip use digital camera ) , one conventional another AFI endoscopy . There also rotary filter allow blue , red green light generate selectively . The video processor construct video image ( AFI image normal optical image ) base signal provide CCD distal end endoscope . In system , normal squamous non-dysplastic BE appear green dysplastic area appear magenta/purplish . Targeted biopsy obtain area abnormal fluorescence . Both NBI AFI equipment supply Olympus America Inc. Standard Endoscopy : Patients undergo EGD biopsy use standard diagnostic video endoscope ( Olympus , GIF 140 160 ) use Seattle protocol - 4 quadrant biopsy use standard biopsy forceps every 2 cm ; store separate jar . Histology : All biopsy specimen stain H &amp; E alcian blue pH 2.5 &amp; review two pathologist ( SM ) ( DL ) , one site , blind NBI/AF result pattern . Any disagreement histological diagnosis resolve consensus diagnosis . Dysplasia classify dysplasia , LGD , HGD adenocarcinoma . Data Collection : Patient demographic , order randomization , endoscopy finding ( BE length , NBI pattern , AFI pattern ) , procedure time , number biopsy histology report collect record study coordinator . All information transfer ACCESS database Statistical Power &amp; Data Analysis : For primary outcome , determine NBI/AFI target biopsy diagnose BE ( intestinal metaplasia ) 90 % patient assume standard endoscopy biopsy diagnose Barrett 's 70 % , would need 122 patient order detect significant difference two 80 % power type I error rate 5 % use McNemar 's test pair dichotomous response . For secondary outcome detection HGD base number biopsy harbor HGD . If assume NBI/AFI detect area HGD ( within BE segment ) 90 % biopsy irregular/distorted pattern compare 60 % standard endoscopy , would need study 59 areas/biopsies HGD order detect significant difference two 80 % power type 1 error rate 5 % use McNemar 's test pair dichotomous response . If enroll least 10-12 patient HGD average BE length 5 cm , able evaluate &gt; 60 area HGD procedure . Each site enroll approximately 30-35 BE patient ( include 5-6 HGD ) year . McNemar 's test use compare paired categorical data continuous pair data compare use non-parametric method Wilcoxon Sign Rank Test . A p value &lt; 0.05 consider significant . For initial 30 consecutive patient enrol study , inter-observer variability study mucosal vascular pattern autofluorescence pattern .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<criteria>Patients suspect Barrett 's esophagus endoscopy Age &gt; 18 year Ability provide write informed consent Presence erosive esophagitis Visible nodule , lesion within Barrett 's esophagus segment Endoscopist aware biopsy result Inability obtain biopsy due anticoagulation varix</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>GERD</keyword>
	<keyword>NBI</keyword>
	<keyword>AFI</keyword>
	<keyword>IM</keyword>
	<keyword>SSBE</keyword>
	<keyword>LSBE</keyword>
	<keyword>LGD</keyword>
	<keyword>HGD</keyword>
</DOC>